<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557878</url>
  </required_header>
  <id_info>
    <org_study_id>LPGF vs hypertonic dextrose</org_study_id>
    <nct_id>NCT04557878</nct_id>
  </id_info>
  <brief_title>Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction</brief_title>
  <official_title>Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction (A Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nourhan M.Aly</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alexandria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of the study is to compare clinically, radiographically and biochemically the effect&#xD;
      of intra- articular injection of hypertonic dextrose with a stabilization appliance and the&#xD;
      intra- articular injection of 2 ml of liquid phase concentrated growth factor with a&#xD;
      stabilization appliance as a prolotherapy for temporomandibular joint anterior disc&#xD;
      displacement without reduction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty four patients with anterior disc displacement without reduction will be selected from&#xD;
      those attending the Prosthodontic Department, Faculty of Dentistry, Alexandria University and&#xD;
      diagnosed clinically and by magnetic resonance imaging. Patients will be randomly assigned&#xD;
      into 2 study groups each comprising 12 patients. Group I will receive an intra-articular&#xD;
      injection of hypertonic dextrose in conjugation with a maxillary CAD/CAM full-arch hard clear&#xD;
      acrylic stabilization appliance while group II will receive an intra-articular injection of&#xD;
      LPCGF in conjugation with a maxillary CAD/CAM full-arch hard clear acrylic stabilization&#xD;
      appliance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 6, 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum mouth opening</measure>
    <time_frame>up to 6 months</time_frame>
    <description>This will be evaluated using Helkimo Anamnestic index (Ai) which comprises the following classes: Ai0 - absence of subjective symptoms of dysfunction; AiI -mild symptoms, such as TMJ sounds, including clicking and crepitation, and feelings of stiffness or fatigue of the jaws; and AiII - severe symptoms of dysfunction, such as difficulty in opening the mouth wide, locking, luxations, pain on movement, and facial and jaw pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disc-condyle relationship</measure>
    <time_frame>6 months</time_frame>
    <description>This will be evaluated using magnetic resonance imaging (MRI) to assess the position of the articular disc and the condyle and the mandibular fossa</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myeloperoxidase enzyme activity</measure>
    <time_frame>6 months</time_frame>
    <description>This will be evaluated by using Myeloperoxidase enzyme assay kits for detection and quantitation of myeloperoxidase activity levels.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Temporomandibular Joint Disorders</condition>
  <condition>Temporomandibular Disorder</condition>
  <arm_group>
    <arm_group_label>Hypertonic Dextrose Solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Liquid Phase Concentrated Growth Factor (LPCGFs)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hypertonic Dextrose Solution</intervention_name>
    <description>Patients in this group will receive an intra-articular injection of 12.5% hypertonic dextrose solution, once every month for three consecutive months, in conjugation with a maxillary CAD/CAM full-arch hard clear acrylic stabilization appliance.The point of needle entry will be 1 cm below the apex of the zygomatic arch and guided by ultrasound to ensure intra-articular injection in the superior joint space.</description>
    <arm_group_label>Hypertonic Dextrose Solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Liquid Phase Concentrated Growth Factor (LPCGFs)</intervention_name>
    <description>Patients in this group will receive single intra-articular injection of LPCGF in conjugation with a maxillary CAD/CAM full-arch hard clear acrylic stabilization appliance.</description>
    <arm_group_label>Liquid Phase Concentrated Growth Factor (LPCGFs)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with painful TMJ.&#xD;
&#xD;
          -  Patients with limited mouth opening (MMO &lt;40mm).&#xD;
&#xD;
          -  Patients with anterior disc displacement without reduction confirmed by MRI.&#xD;
&#xD;
          -  Presence of full or nearly full complement of natural teeth.&#xD;
&#xD;
          -  Patients with angle class I occlusion.&#xD;
&#xD;
          -  Patients with RCP not greater than 2mm and with no open bite.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have anterior disc dislocation with reduction detected by MRI.&#xD;
&#xD;
          -  Inability or unwillingness to undergo magnetic resonance imaging (MRI) such as&#xD;
             implanted electronic devices.&#xD;
&#xD;
          -  Patients having uncontrolled systemic disease, hematologic or neurologic disorders or&#xD;
             inflammatory diseases.&#xD;
&#xD;
          -  Patients under anticoagulant drug therapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariam M. Bahgat, M.Sc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadia R El-Helw, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Abdelhamid, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Fata, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Dentistry, Alexandria University, Egypt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Medhat Ashour, PhD</last_name>
    <role>Study Director</role>
    <affiliation>High Institute of Public Health, Alexandria University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariam Bahgat, M.Sc</last_name>
    <phone>01222882107</phone>
    <phone_ext>+2</phone_ext>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nourhan M. Aly, M.Sc</last_name>
    <phone>01006639489</phone>
    <phone_ext>+2</phone_ext>
    <email>nourhan.moustafa@alexu.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Dentistry, Alexandria University</name>
      <address>
        <city>Alexandria</city>
        <zip>21512</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>September 15, 2020</last_update_submitted>
  <last_update_submitted_qc>September 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Alexandria</investigator_affiliation>
    <investigator_full_name>Nourhan M.Aly</investigator_full_name>
    <investigator_title>Assistant Lecturer of Dental Public Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

